The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study
Journal of Drugs in Dermatology · 2023
DOI: 10.36849/jdd.7295 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2023. Verfasst von Melinda Gooderham und 20 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 44-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gooderham, M., Kircik, L., Zirwas, M., Lee, M., Kempers, S., Draelos, Z., Ferris, L., Jones, T., Saint-Cyr Proulx, E., Bissonnette, R., Bhatia, N., Koppel, R., Guenthner, S., Eads, K., Welgus, H., Merritt, C., Elias, M., Navale, L., Higham, R., …, & Berk, D. (2023). The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7295
Vancouver
Gooderham M, Kircik L, Zirwas M, Lee M, Kempers S, Draelos Z, et al. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study. Journal of Drugs in Dermatology. 2023. doi:10.36849/jdd.7295
BibTeX
@article{Gooderham2023,
author = {Gooderham, Melinda and Kircik, Leon and Zirwas, Matthew and Lee, Mark and Kempers, Steven and Draelos, Zoe and Ferris, Laura and Jones, Terry and Saint-Cyr Proulx, Etienne and Bissonnette, Robert and Bhatia, Neal and Koppel, Robert and Guenthner, Scott and Eads, Kimmie and Welgus, Howard and Merritt, Charlotte and Elias, Meg and Navale, Lynn and Higham, Robert and Droege, Michael and Berk, David},
title = {The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study},
journal = {Journal of Drugs in Dermatology},
year = {2023},
doi = {10.36849/jdd.7295}
}
EUVIMED